Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MILLER, J. M.
Right arrow Articles by GINSBERG, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MILLER, J. M.
Right arrow Articles by GINSBERG, M.
(Chest. 1954;26:166-179.)
© 1954 American College of Chest Physicians

Tryptar in Intrathoracic Disease

JOSEPH M. MILLER M.D.; BEVERLY H. WHITE M.D.; and MILTON GINSBERG M.D.1

1 Surgical Service, Veterans Administration, Fort Howard, Maryland.

Tryptar provides the surgeon with another excellent therapeutic agent for the treatment of intrathoracic diseases. Fibrin is digested without harm to living tissues. Blood and pus are liquified and can be more easily removed. The excellent results obtained from the use of tryptar in this small series of patients with intrathoracic diseases suggests that further trial be given to the use of the enzyme in similar conditions.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1954 by the American College of Chest Physicians.